- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01812499
Common Causes of Blood Transfusion Events in a University Hospital: Analysis of Incident Reports
Common Causes of Blood Transfusion Events in a University Hospital: Analysis of Incident Reports.
Inhospital the blood transfusion process consists of many phases: ordering the blood product, analysis of the blood sample, delivery, transport and storage of the blood product and administration. In each of these phases (near) accidents may occur. A severe transfusion incident refers to the transfusion of a wrong blood product, whereas a near miss is detected before transfusion.
In 2010 the University Hospitals Leuven introduced a new electronic patient incident report system for transfusion events.
In this study the investigators will analyze the reported blood transfusion events to detect the most common causes of blood transfusion events and the weakest link in the blood transfusion chain.
Study Overview
Status
Conditions
Detailed Description
A retrospective survey will be conducted of all transfusion events reported in the University Hospitals Leuven between January 2011 and July 2012. Both severe accidents and near misses will be included.
Data will be drawn from the incident report system. Data concerning the number of transfused blood products will be required from the Medical Administration Service.
Events will be classified according to the severity and the cause of the event. The different settings where the events took place will be compared using a chi-square test (p<0,05).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Leuven, Belgium
- University Hospitals Leuven
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- all transfusion events reported in the University Hospitals Leuven between January 2011 and July 2012
- Both severe accidents and near misses were included
Exclusion Criteria:
- Transfusion reactions
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Severity of inhospital blood transfusion events
Time Frame: up to 1,5 years
|
included events will be classified into near misses or severe incidents
|
up to 1,5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Causes of inhospital blood transfusion events
Time Frame: up to 1,5 years
|
Events are classified into human error, technical problems, deficiency of the blood product and others. Events will also be classified considering the phase in the blood transfusion process. Causes will be studied hospital wide and per setting were the event took place. |
up to 1,5 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of inhospital blood transfusion events
Time Frame: up to 1,5 years
|
The number of transfusion events divided by the total number of transfused blood products in the study period
|
up to 1,5 years
|
Is there a relation between misidentification events and the setting where the event took place?
Time Frame: up to 1,5 years
|
The different settings where the events took place will be compared using a chi-square test (p<0,05).
|
up to 1,5 years
|
Collaborators and Investigators
Investigators
- Study Director: Timothy Devos, MD, PhD, Department of Hematology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
- Principal Investigator: Els Costermans, RN, Department of Hematology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- S55141
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Transfusion Events
-
Wellspect HealthCareCompletedArthroplasty, Replacement, Knee | Blood Transfusion | Blood Transfusion, AutologousPoland
-
Wellspect HealthCareCompletedBlood Transfusion | Arthroplasty, Replacement, Hip | Blood Transfusion, AutologousAustria, Netherlands, Norway, Spain
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedBlood Transfusion | Orthopedic Surgery | Orthopedic Procedures | Cardiovascular Surgical Procedure | Blood Transfusion, Autologous
-
University of Colorado, DenverCompleted
-
Diskapi Teaching and Research HospitalCompleted
-
Clinic for Cardiovascular Diseases MagdalenaCompleted
-
Dartmouth-Hitchcock Medical CenterBEST research collaborativeCompletedBlood TransfusionNorway, United States, Australia, Canada, United Kingdom, Brazil
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI); University of Pittsburgh; Strathmore... and other collaboratorsNot yet recruiting
-
McMaster UniversityCanadian Institutes of Health Research (CIHR)Completed
-
Cardiochirurgia E.H.Completed